Shots: BI and Healx team up to discover new indications targeting rare neurological diseases by harnessing Healx’s AI-based drug discovery platform, Healnet to advance BI’s pipeline The collaboration combines BI’s expertise for drug development, especially in rare neurological conditions with Healx’s AI-powered drug discovery platform. Healx will utilize its data analysis and technological capabilities to […]Read More
Tags : Rare Neurological Diseases
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US